Repositioning approved drugs for the treatment of problematic cancers using a screening approach

Advances in treatment strategies together with an earlier diagnosis have considerably increased the average survival of cancer patients over the last four decades. Nevertheless, despite the growing number of new antineoplastic agents introduced each year, there is still no adequate therapy for probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Varbanov, Hristo P., Kuttler, Fabien, Banfi, Damiano, Turcatti, Gerardo, Dyson, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293254/
https://www.ncbi.nlm.nih.gov/pubmed/28166232
http://dx.doi.org/10.1371/journal.pone.0171052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293254/
https://www.ncbi.nlm.nih.gov/pubmed/28166232
http://dx.doi.org/10.1371/journal.pone.0171052

Ejemplares similares